Clinical leadership
Define pilot boundaries, workflow suitability, escalation expectations, supervision and acceptance criteria.
Healthcare · Pilot readiness
A controlled pilot needs shared understanding across clinical, operational, IT, procurement, privacy and executive stakeholders.
A governed starting point
Medi AI+ is a pre-clinical R&D programme. Any future pilot discussion is subject to technical validation, institutional review, privacy and cybersecurity assessment, procurement, and applicable regulatory requirements.
Public information intentionally avoids proprietary architecture, internal implementation details and commercial terms.
Who should be involved
Each stakeholder group brings a different part of the operating boundary into view.
Define pilot boundaries, workflow suitability, escalation expectations, supervision and acceptance criteria.
Review network readiness, access controls, local data handling, device onboarding and security requirements.
Coordinate device placement, peripheral readiness, power, physical setup, safety review and equipment workflows.
Confirm privacy obligations, data minimisation, retention expectations, access governance and institutional approvals.
Review commercial process, timelines, site coordination, vendor onboarding and support expectations.
Align pilot goals with operational risk, patient safety, local AI adoption and deployment governance.
Disclosure boundary
Appropriate materials may be shared with qualified stakeholders under agreed confidentiality, compliance and procurement processes.
Explore Medi AI+Pilot & Regulatory Notice
Medi AI+ is currently a pre-clinical engineering programme. Product concepts and pilot configurations shown on this website are for stakeholder evaluation, controlled pilot planning, and qualified commercial discussion only. They are not represented as HSA-registered or approved medical devices, diagnostic systems, treatment systems, autonomous clinical decision-making, or substitutes for professional clinical judgement. It is not approved for diagnosis, treatment, or unsupervised clinical use. Any Singapore deployment must undergo appropriate institutional review, clinical governance, cybersecurity assessment, procurement checks, PDPA/data protection review, and, where applicable, Health Sciences Authority (HSA) medical-device classification, registration, licensing, and approval processes before clinical or operational use.